Three mutants of Lactococcus lactis subsp. lactis MG1363, termed EthR, DauR, and RhoR, were selected for resistance to high concentrations of ethidium bromide, daunomycin, and rhodamine 6G, respectively. These mutants were found to be cross resistant to a number of structurally and functionally unrelated drugs, among which were typical substrates of the mammalian multidrug transporter (P-glycoprotein) such as daunomycin, quinine, actinomycin D, gramicidin D, and rhodamine 6G. The three multidrug-resistant strains showed an increased rate of energy-dependent ethidium and daunomycin efflux compared with that of the wild-type strain. This suggests that resistance to these toxic compounds is at least partly due to active efflux. Efflux of ethidium from the EthR strain could occur against a 37-fold inwardly directed concentration gradient. In all strains, ethidium efflux was inhibited by reserpine, a well-known inhibitor of P-glycoprotein. lonophores which selectively dissipate the membrane potential or the pH gradient across the membrane inhibited ethidium and daunomycin efflux in the wild-type strain, corresponding with a proton motive force-driven efflux system. The ethidium efflux system in the EthR strain, on the other hand, was inhibited by ortho-vanadate and not upon dissipation of the proton motive force, which suggests the involvement of ATP in the energization of transport.
The partial inhibition of ethidium efflux by ortho-vanadate and nigericin in the DauR and RhoR strains suggest that a proton motive force-dependent and an ATP-dependent system are expressed simultaneously. This is the first report of an ATP-dependent transport system in prokaryotes which confers multidrug resistance to the organism.
Multidrug resistance (MDR) is the intrinsic or acquired resistance of cells to various structurally and functionally unrelated toxic compounds. For various mammalian cells, it has been established that MDR is the result of active extrusion of drugs from the cells, a process that is catalyzed by an ATP-dependent transport protein termed P-glycoprotein or MDR1 (14) . P-glycoprotein confers resistance to vinca alkaloids, anthracyclines, actinomycin D, valinomycin, gramicidin D, and phosphonium ions (4, 7, 9) . P-glycoprotein is classified among members of the ATP-binding cassette (ABC) proteins (15) or traffic ATPases (26) , to which belong prokaryotic and eukaryotic transport systems that facilitate either uptake or extrusion of substrates. Because of the importance of MDR in the failure of drug-based treatment of cancers and parasital infections, most attention has been focused on eukaryotic MDR systems. Recently, however, several MDR-like systems in both gram-positive (31, 42) and gram-negative (11, 20, 23) bacteria as well as in archaea (27) have been described. The occurrence of acquired resistance in bacteria, and especially in pathogenic bacteria like enterococci, staphylococci (35) , and Mycobacterium tuberculosis (3), also poses serious problems to public health. MDR in these organisms is believed to be the result of active extrusion by broad-specificity transport systems.
Resistance of bacteria to the ethidium ion has been known for a long time (16) . Ethidium readily crosses the membrane by passive diffusion and intercalates between the bases of polynucleotides, thereby exerting its growth-inhibitory and mutagenic effects. The presently characterized bacterial ethidium resistance mechanisms are all membrane-located extrusion systems. They can be divided into two homology groups. To the first group belong several tetracycline and other antibiotic resistance efflux systems, multidrug effiux systems, and sugar uptake systems (2, 37) . Recently, a mammalian vesicular amine transporter was added to this group (22) . These proteins have either 12 or 14 putative membranespanning helices, and a few of these carriers have been shown to catalyze secondary transport (reviewed in references 21 and 32) . The second group includes the products of highly similar MDR genes from various Staphylococcus species and a methyl viologen resistance determinant from Escherichia coli (8) . The polypeptides of this group have only four putative membranespanning helices and are probably also proton gradient-driven extrusion systems. The ethidium efflux systems of both homology groups have different specificities, but all confer crossresistance to or catalyze efflux of unrelated compounds, like acriflavine, phosphonium ions, quaternary ammonium ions, aminoglycosides, rhodamine 6G, and chloramphenicol (8, 25, 31, 39) .
In this paper we describe the isolation of three For experiments with washed cell suspensions, exponentially growing cultures were harvested and washed three times in 50 mM potassium phosphate, pH 7.0, supplemented with 5 mM MgSO4. For inhibitor studies with ortho-vanadate, potassium phosphate was replaced by potassium-HEPES [4-(2-hydroxyethyl)-1-piperazinethane-sulfonate] at equimolar concentrations. When necessary, cells were de-energized by incubation for 30 min with 10 mM 2-deoxyglucose at 30°C followed by three washing steps in the appropriate buffer.
Selection of drug-resistant mutants. Mutants of L. lactis were isolated by selecting for growth in medium supplemented with the toxic compound. Small amounts of exponentially growing cultures were transferred to medium containing an increased concentration of the toxic compound, after which this step was repeated with stepwise increasing concentrations. The final concentrations used were 200 puM ethidium bromide, 200 puM daunomycin, or 100 puM rhodamine 6G, and the corresponding mutants were termed EthR, DauR, and RhoR, respectively.
Determination of growth rate. The growth rate was determined in sterile low-protein-binding microplates (Greiner, Frickenhausen, Germany). Aliquots of 250 p,1 of medium A with various concentrations of different drugs were inoculated with exponential growing cultures of the wild-type and mutant strains of L. lactis. Growth was monitored by measuring the A690 every 10 min in a multiscan photometer (Titertek Multiskan MCC/340 MKII; Flow Laboratories, Lugano, Switzerland). Growth rates were determined by nonlinear leastsquares fitting of the absorbance data to an equation describing bacterial growth (43).
Ethidium eftlux. (i) A washed and de-energized cell suspension (0.2 mg of protein per ml) was incubated at 30°C with 5 ,uM ethidium bromide and after 2 h was energized with glucose (25 mM). At various times 0.75-ml samples were centrifuged for 3 min at maximal speed (15,000 x g) in an Eppendorf centrifuge. Supernatant (0.5 ml) was carefully pipetted off and diluted into 1.5 ml of buffer containing a 0.1 mM concentration of base pairs of fragmented calf thymus DNA (prepared as described below). The fluorescence of this solution was measured with excitation and emission wavelengths of 500 and 580 nm, respectively, using slit widths of 5 and 10 nm, respectively. Fluorescence was measured with a Perkin-Elmer LS 50B fluorometer with computer-controlled data acquisition and storage. A calibration curve with ethidium concentrations in the range of 0 to 10 ,uM was found to be linear and was used to estimate the concentration in the supernatant. (ii) Ethidium efflux was also estimated from the fluorescence of the ethidium-polynucleotide complex in the cell. Ethidium displays approximately a 10-fold increase in fluorescence quantum yield upon binding to DNA or RNA (19) . This property was used to monitor indirectly the intracellular ethidium concentration (18, 24) . A washed cell suspension (0.2 mg of protein per ml) was incubated for 10 min with 10 ,uM ethidium bromide at 30°C to allow the ethidium to diffuse across the membrane. Ethidium efflux was initiated by the addition of glucose (25 mM). Fluorescence was integrated every 0.5 s with excitation and emission wavelengths of 500 and 580 nm, respectively. No corrections were made for light scatter or absorption by cells, since these parameters varied only slightly during the course of an experiment.
Free internal ethidium concentration. The free intracellular ethidium concentration was estimated from the ethidium fluorescence in cells, assuming rapid equilibration between ethidium bound to polynucleotides and the internal pool of free ethidium (40) . Cell suspensions were de-energized with 10 mM 2-deoxyglucose, and the transmembrane ion gradients were dissipated with nigericin (1 ,uM) (Fig. 3) . The initial ethidium efflux rates for the EthR, DauR, and RhoR strains were approximately seven-, five-, and threefold higher, respectively, than that for the wild-type strain. The difference in the stimulation of the efflux rate inferred from direct ( Fig. 2) and indirect (Fig. 3) measurements is most likely due to the different ethidium concentrations at which transport was assayed. The differences in the ethidium efflux rates correspond to the differences in ethidium sensitivities of the various strains (Fig. 1) . The concentration gradient. These observations indicate that ethidium efflux is mediated by energy-dependent processes.
Inhibition by reserpine. Reserpine is known as a potent inhibitor of the MDR1 P-glycoprotein and of the Bacillus subtilis MDR carrier (4, 31) . Cells were preincubated with reserpine (10 ,ug/ml) prior to the addition of ethidium. Reserpine inhibited ethidium efflux completely in the wild-type and DauR strains (Fig. 5A, RES) and RhoR (data not shown) and partially in EthR (Fig. 6A, RES) . Energization Fig. 5A ; data not shown) is consistent with such a mechanism, i.e., passive equilibration of ethidium with the membrane potential. The absence of this phenomenon in EthR cells suggest that ethidium efflux in this strain is not completely inhibited by reserpine.
Presence of a secondary drug extrusion system. To establish the driving force for ethidium efflux in L. lactis, ionophores were used to selectively dissipate the components of Ap. Dissipation of the proton gradient (ApH) by the electroneutral proton/potassium antiporter nigericin or by the addition of the weak acid potassium acetate inhibited ethidium efflux in the wild-type and DauR strains (Fig. SA, NIG) and in the RhoR strain (data not shown). These results indicate that the ApH is a driving force for ethidium efflux. Addition of the potassium ionophore valinomycin enhanced the efflux of ethidium in all strains tested (Fig. 5A and 6A, VAL) . Valinomycin dissipates the As, with a concomitant increase in the ApH (28) . This decrease in the A* will lower the ethidium influx and/or stimulate the efflux irrespective of whether the Ap is directly involved in the efflux via the transport protein(s). Indications for the involvement of the A*4 in the ethidium efflux process were obtained from ethidium uptake experiments in cells in which the ethidium efflux pump was inactivated. Cell suspensions were energized with glucose and incubated at room temperature in the presence or absence of reserpine or nigericin. Uptake was initiated upon the addition of ethidium bromide (Fig. 5B) . Ethidium uptake in reserpine-treated cells was higher than that in nigericin treated cells (ApH poised to zero), indicating that the Aq; is involved in ethidium efflux.
Taken together, the results suggest that ethidium efflux in wild-type cells is mediated by a secondary transport system and that both components of Ap function as a driving force.
Presence of a primary drug extrusion system. In contrast to its effect on the wild-type, DauR, and RhoR strains, nigericin had only a minor effect on ethidium efflux in EthR (Fig. 6A,  NIG) 
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indicating that ethidium efflux was inhibited (Fig. 6B) . Arsenate (0.5 mM) and N,N'-dicyclohexylcarbodiimide (0.5 mM) inhibited ethidium efflux only partially, while sodium azide (0.5 mM) had no effect (data not shown). ortho-Vanadate inhibited ethidium efflux in DauR and RhoR partially but did not affect ethidium efflux from the wild-type strain (data not shown).
Since arginine metabolism via the arginine deiminase (ADI)
pathway and the concomitant synthesis of ATP are not affected by ortho-vanadate, these observations indicate that the efflux system is ATP driven. Taken as a whole, the experiments with the metabolic inhibitors indicate that L. lactis is able to express at least two different (ethidium) efflux activities. One activity is present in the wild-type strain and forms the major system for ethidium efflux in DauR and RhoR. This system is coupled to Ap. The second system is most likely coupled to ATP and is responsible for ethidium efflux in EthR. This system appears to play a minor role in the efflux from DauR and RhoR strains.
Daunomycin is a substrate of the L. lactis MDR transporters. Daunomycin fluorescence is quenched upon binding to polynucleotides, and this property can be used to determine the internal daunomycin concentration. Efflux of this probe results in an increase in the fluorescence signal (38) . The initial rate of daunomycin efflux from wild-type cells was increased upon energization with glucose (25 mM). The daunomycin efflux rate in EthR was much higher than that in the wild-type strain (Fig. 7) . Similar results were obtained with DauR and RhoR strains (data not shown). Moreover, as observed for ethidium efflux, daunomycin efflux was sensitive to valinomycin and nigericin in wild-type cells but not in EthR cells. These data indicate that daunomycin is also a substrate of the lactococcal MDR transporters and that an increased resistance isolated by selecting for resistance to three structurally unrelated toxic compounds, i.e., ethidium bromide, daunomycin, and rhodamine 6G. All three mutants showed a similar pattern of cross-resistance to a variety of unrelated drugs, among which were typical substrates for the human P-glycoprotein. Analogous to MDR in mammalian cells and different bacteria, the MDR phenotype in L. lactis is associated with active drug extrusion. This conclusion is based on measurements of both the internal and external drug concentrations with fluorometric assays. Drug efflux in the three MDR mutants is an energy-dependent enzyme-mediated process as demonstrated by (i) the stimulation of drug efflux upon energization with glucose (each mutant exhibited an energy-dependent efflux of both ethidium and daunomycin which was higher than that in the wild-type strain) and (ii) drug efflux against a concentration gradient. The increased resistance of the mutants to ethidium and daunomycin must be at least partially due to an increase in extrusion of these compounds. It is likely that the increased drug extrusion is also responsible for the cross-resistance to the other compounds tested (e.g., rhodamine 6G, actinomycin D, gramicidin D, and quinine). Increased drug efflux in the different mutants might be the result of an increased expression of the systems and/or an increased catalytic efficiency in transporting the drugs.
Analysis of the energy coupling to ethidium efflux indicates that in L. lactis more than one transport system can be involved in the efflux process. Although it cannot be excluded that the peptide ionophore nigericin (and perhaps valinomycin) is a substrate of the lactococcal drug efflux system, the observation that dissipation of the ApH by nigericin and weak acids (e.g., acetate) abolishes essentially all efflux activity strongly suggests that this process is coupled to the ApH. Since dissipation of the ApH component of the Ap at pH 6.5 is not sufficient to block ethidium effiux from the wild-type strain completely, an involvement of the A1f in the energy coupling appears most likely. These observations are best explained by an electrogenic ethidium/proton antiport system that couples the efflux of ethidium (carrying one positive charge) to the uptake of at least two protons. Ethidium extrusion from EthR cells is inhibited by the phosphate analog ortho-vanadate and not by nigericin, protonophores, or weak acids that dissipate the Ap or components thereof. This is indicative of an ATP-dependent transport system. Reserpine, a plant alkaloid which inhibits the transport catalyzed by the vesicular amine transporter (1), P-glycoprotein (4, 7), and the B. subtilis MDR carrier (1) , also inhibits ethidium efflux in wild-type L. lactis and in the DauR, RhoR, and EthR strains. Apparently, both the Ap-driven and the ATP-dependent systems are inhibited by reserpine, although inhibition of the latter system is less pronounced than that of the Ap-dependent system. It is worth noting that drug efflux occurs against a concentration gradient J. BACTERIOL.
in both the wild-type and EthR strains. To dissect the putative Ap-driven and ATP-dependent drug efflux activities in L. lactis, a genetic approach is currently being pursued.
The pronounced extrusion activity in the EthR mutant is not mediated by the previously described ATP-driven 2',7'-bis-(2-carboxyethyl)-5[and-6]-carboxyfluorescein (BCECF) efflux system of L. lactis subsp. lactis MU (30) . This conclusion is based on the observations that the rate of ethidium efflux is not changed in a mutant which has a fourfold-lowered rate of BCECF efflux and that the rate of BCECF efflux in the EthR strain is the same as that in the wild-type (29) .
The presence of an ATP-dependent transport system involved in MDR in prokaryotes has not been described before. The ATP-dependent efflux systems which have been described for prokaryotes extrude or confer resistance to only a small range of related compounds (recently reviewed in references 5 and 12). Furthermore, the similarity of these systems to P-glycoprotein is restricted to highly conserved regions around the nucleotide-binding motifs (10, (34) (35) (36) which bear no direct relationship to a MDR phenotype. Although the gene(s) encoding the ATP-dependent ethidium efflux system has not yet been isolated and a structural similarity cannot be established, the lactococcal system has a number of functional properties in common with P-glycoprotein; i.e., both systems facilitate the efflux of a wide variety of unrelated drugs and are inhibited by ortho-vanadate and reserpine.
Multidrug efflux systems in both gram-positive and gramnegative organisms that are driven by the Ap have been described previously (23, 31, 39, 42) . These energy-dependent efflux systems are believed to be drug/proton antiporters (17, 23, 31, 41) , although solid evidence for such a mechanism is lacking. The physiological function of the ethidium extrusion system(s) could be related to a need for the organism to extrude toxic compounds encountered in the natural habitat, such as toxins produced by microorganisms or plants. Many of these compounds are both water and lipid soluble (7, 13) .
